ePrints

Management of antithrombotic therapy in patients at high bleeding risk after percutaneous coronary intervention for acute coronary syndromes: a case report

Lookup NU author(s): Dr Mohaned Egred

Downloads

• Published version [.pdf]

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).

Abstract

© The Author(s) 2022.Background: Choosing antithrombotic therapy for patients at high bleeding risk, particularly those requiring long-term anticoagulant therapy, who have acute coronary syndromes (ACS) and/or undergoing percutaneous coronary intervention (PCI) is becoming increasingly complex. Case summary: A 78-year-old women was hospitalized with chest pain and a diagnosis of non-ST-elevation ACS was made. It was decided that the patient should undergo coronary angiogram with a view for angioplasty. Subsequently, she underwent successful PCI to the left anterior descending artery. Shortly after PCI, she was noted to be in atrial fibrillation. Furthermore, she had per rectal bleeding and acute kidney injury, which were managed conservatively. Aspirin and ticagrelor were stopped and she was discharged on dual antithrombotic therapy with clopidogrel and apixaban. Discussion: Available evidence, driven mainly from expert consensus documents, advocates a case-by-case comprehensive evaluation that integrates patient- and procedure-related factors to assess patients for thrombotic and bleeding tendencies to identify those who may gain most net clinical benefit of antithrombotic combination therapy. In general, if thrombotic drivers prevail, an augmented antithrombotic regime with a view for a longer duration should be planned, and if bleeding drivers prevail, a de-escalated regime with a view for a shorter duration should be sought.

Publication metadata

Author(s): Mahmood H, Shahid F, Egred M, Farag M

Publication type: Article

Publication status: Published

Journal: European Heart Journal - Case Reports

Year: 2022

Volume: 6

Issue: 6

Online publication date: 20/06/2022

Acceptance date: 28/05/2022

Date deposited: 30/06/2023

ISSN (electronic): 2514-2119

Publisher: Oxford University Press

URL: https://doi.org/10.1093/ehjcr/ytac224

DOI: 10.1093/ehjcr/ytac224

Altmetrics

Share